X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA PFIZER SHASUN PHARMA/
PFIZER
 
P/E (TTM) x 123.9 33.4 370.8% View Chart
P/BV x 8.5 5.0 171.5% View Chart
Dividend Yield % 0.2 0.8 30.7%  

Financials

 SHASUN PHARMA   PFIZER
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
PFIZER
Mar-17
SHASUN PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs942,055 4.6%   
Low Rs461,651 2.8%   
Sales per share (Unadj.) Rs214.2429.8 49.8%  
Earnings per share (Unadj.) Rs5.373.6 7.2%  
Cash flow per share (Unadj.) Rs15.887.4 18.1%  
Dividends per share (Unadj.) Rs1.0020.00 5.0%  
Dividend yield (eoy) %1.41.1 132.6%  
Book value per share (Unadj.) Rs53.3528.7 10.1%  
Shares outstanding (eoy) m56.6245.75 123.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.3 7.6%   
Avg P/E ratio x13.125.2 52.0%  
P/CF ratio (eoy) x4.421.2 20.8%  
Price / Book Value ratio x1.33.5 37.4%  
Dividend payout %18.727.2 69.0%   
Avg Mkt Cap Rs m3,95884,777 4.7%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m2,1643,039 71.2%   
Avg. sales/employee Rs ThNM6,925.9-  
Avg. wages/employee Rs ThNM1,070.4-  
Avg. net profit/employee Rs ThNM1,186.3-  
INCOME DATA
Net Sales Rs m12,12719,663 61.7%  
Other income Rs m2291,012 22.7%   
Total revenues Rs m12,35620,674 59.8%   
Gross profit Rs m1,0093,491 28.9%  
Depreciation Rs m594629 94.3%   
Interest Rs m41510 4,324.0%   
Profit before tax Rs m2303,864 5.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m01,304 0.0%   
Tax Rs m-731,801 -4.0%   
Profit after tax Rs m3023,368 9.0%  
Gross profit margin %8.317.8 46.9%  
Effective tax rate %-31.746.6 -67.9%   
Net profit margin %2.517.1 14.5%  
BALANCE SHEET DATA
Current assets Rs m6,88420,789 33.1%   
Current liabilities Rs m8,4567,870 107.5%   
Net working cap to sales %-13.065.7 -19.7%  
Current ratio x0.82.6 30.8%  
Inventory Days Days6260 103.1%  
Debtors Days Days10822 479.7%  
Net fixed assets Rs m4,9709,175 54.2%   
Share capital Rs m113458 24.8%   
"Free" reserves Rs m2,87523,731 12.1%   
Net worth Rs m3,02024,189 12.5%   
Long term debt Rs m1,81725 7,269.6%   
Total assets Rs m13,34732,706 40.8%  
Interest coverage x1.6403.5 0.4%   
Debt to equity ratio x0.60 58,222.3%  
Sales to assets ratio x0.90.6 151.1%   
Return on assets %5.410.3 52.0%  
Return on equity %10.013.9 71.8%  
Return on capital %13.321.4 62.3%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,84363 9,288.7%   
Fx outflow Rs m2,1734,067 53.4%   
Net fx Rs m3,669-4,004 -91.6%   
CASH FLOW
From Operations Rs m3983,288 12.1%  
From Investments Rs m-1,635-2,496 65.5%  
From Financial Activity Rs m1,309-826 -158.4%  
Net Cashflow Rs m71-35 -205.8%  

Share Holding

Indian Promoters % 39.2 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 3.6 7.5 48.0%  
FIIs % 17.6 4.9 359.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 23.7 167.1%  
Shareholders   20,750 85,207 24.4%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   STERLING BIOTECH  NOVARTIS  ALEMBIC PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  

Compare SHASUN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Green; Metal Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS